Thomas E. Frooman - Jul 29, 2021 Form 4 Insider Report for CINTAS CORP (CTAS)

Signature
/s/ F. Mark Reuter, as Attorney-in-Fact for Thomas E. Frooman
Stock symbol
CTAS
Transactions as of
Jul 29, 2021
Transactions value $
-$2,855,002
Form type
4
Date filed
8/2/2021, 01:58 PM
Previous filing
Jul 27, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CTAS Common Stock Options Exercise $883K +8.15K +9.24% $108.39 96.4K Jul 29, 2021 Direct
transaction CTAS Common Stock Options Exercise $1M +7.3K +7.58% $137.30 104K Jul 29, 2021 Direct
transaction CTAS Common Stock Options Exercise $371K +2.7K +2.6% $137.30 106K Jul 29, 2021 Direct
transaction CTAS Common Stock Options Exercise $1.52M +7.36K +6.92% $206.99 114K Jul 29, 2021 Direct
transaction CTAS Common Stock Sale -$4.01M -10.2K -8.99% $392.08 103K Jul 29, 2021 Direct F1
transaction CTAS Common Stock Sale -$2.63M -6.69K -6.46% $393.05 96.8K Jul 29, 2021 Direct F2
holding CTAS Common Stock 169 Jul 29, 2021 By ESOP

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CTAS Stock Option (Right to Buy) Options Exercise $0 +8.15K $0.00* 0 Aug 2, 2021 Common Stock 8.15K $108.39 Direct F3
transaction CTAS Stock Option (Right to Buy) Options Exercise $0 +7.3K +730100% $0.00 7.3K Aug 2, 2021 Common Stock 7.3K $137.30 Direct F3
transaction CTAS Stock Option (Right to Buy) Options Exercise $0 +2.7K +269900% $0.00 2.7K Aug 2, 2021 Common Stock 2.7K $137.30 Direct F3
transaction CTAS Stock Option (Right to Buy) Options Exercise $0 +7.36K +99.97% $0.00 14.7K Aug 2, 2021 Common Stock 7.36K $206.99 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $391.68 to $392.68. The Reporting Person undertakes to provide full pricing information to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission upon request.
F2 The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $392.69 to $393.27. The Reporting Person undertakes to provide full pricing information to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission upon request.
F3 The options vest as follows: one-third on the third anniversary of the grant date, one-third on the fourth anniversary of the grant date, and one-third on the fifth anniversary of the grant date.